| Literature DB >> 28097424 |
Mei Xue1, Yan Zhao1, Shunlei Hu1, Xingming Shi1, Hongyu Cui1, Yunfeng Wang2,3.
Abstract
Infection with reticuloendotheliosis virus (REV), a gammaretrovirus in the family Retroviridae, can result in immunosuppression and subsequent increased susceptibility to secondary infections. In the present study, we identified differentially expressed proteins in the spleens of chickens infected with the REV-A HLJ07I strain, using two-dimensional gel electrophoresis on samples from time points coinciding with different phases of the REV life cycle. Differentially expressed proteins were identified using one-dimensional liquid chromatography electrospray ionization tandem mass spectrometry (1D LC ESI MS/MS). Comparative analysis of multiple gels revealed that the majority of changes occurred at early stages of infection. In total, 60 protein spots representing 28 host proteins were detected as either quantitatively (false discovery rate [FDR] ≤0.05 and fold change ≥2) or qualitatively differentially expressed at least once during different sampling points. The differentially expressed proteins identified in this study included antioxidants, molecular chaperones, cellular metabolism, formation of the cytoskeleton, signal transduction, cell proliferation and cellar aging. The present findings provide a basis for further studies to elucidate the role of these proteins in REV-host interactions. This could lead to a better understanding of REV infection mechanisms that cause immune suppression.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28097424 PMCID: PMC5387025 DOI: 10.1007/s00705-016-3180-5
Source DB: PubMed Journal: Arch Virol ISSN: 0304-8608 Impact factor: 2.574
Fig. 1REV genome load in infected spleens. Chickens were infected with the HLJ07I strain of REV and sampled at 7, 14 and 21 days postinfection. Gag copy numbers in 100 ng of spleen RNA were quantitated using real-time RT-PCR. At least three spleen samples were analyzed in duplicate at each sampling time point. The error bars represent standard error of the mean
Fig. 2Representative 2D gel images of REV-infected and uninfected control spleen proteomes at different sampling times. The differentially expressed protein spots are shown in gels with their unique sample spot protein numbers. Arrows indicate the successfully identified protein spots. Please refer to Table 1 for the identities of the proteins in the numbered spots
List of the differentially expressed proteins in spleen identified by MALDI/TOF/TOF and MS/MS analysis
| Spot ID | Protein name | Accession no. | Fold change in expression | pI, MW (kDa) | Protein score | Function | ||
|---|---|---|---|---|---|---|---|---|
| 7 dpi | 14 dpi | 21 dpi | ||||||
|
| ||||||||
| 42 | Beta-actin | gi|63018 | +2.0 | +1.6 | +2.3 | 5.29/42.07 | 505 | Unknown |
| 63 | Alpha-actinin-4 (ACTN4) | gi|45384104 | -1.4 | -1.1 | N | 5.13/104.71 | 528 | Actin binding calcium ion binding |
| 7 | Actin, cytoplasmic type 5 | gi|56119084 | -2.1 | N | N | 5.30/42.15 | 265 | ATP binding |
| 17 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +3.3 | +1.5 | +2.6 | 5.30/42.15 | 235 | ATP binding |
| 18 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.4 | +1.4 | +3 | 5.30/42.15 | 694 | ATP binding |
| 20 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.8 | +1.5 | +2.5 | 5.30/42.15 | 735 | ATP binding |
| 21 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +1.7 | +1.4 | +1.9 | 5.30/42.15 | 576 | ATP binding |
| 22 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +6.1 | +1.9 | +3.1 | 5.30/42.15 | 868 | ATP binding |
| 23 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +14.9 | +5.6 | +2.3 | 5.30/42.15 | 898 | ATP binding |
| 24 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +5.0 | +1.8 | +2.1 | 5.30/42.15 | 715 | ATP binding |
| 25 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +3.0 | +1.2 | +2.4 | 5.30/42.15 | 888 | ATP binding |
| 26 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +5.2 | +1.2 | +2.6 | 5.30/42.15 | 808 | ATP binding |
| 27 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.2 | +1.6 | +1.8 | 5.30/42.15 | 938 | ATP binding |
| 28 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +3.1 | +11.5 | +2.1 | 5.30/42.15 | 781 | ATP binding |
| 29 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +3.6 | +1.6 | +1.8 | 5.30/42.15 | 728 | ATP binding |
| 30 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +9.8 | N | N | 5.30/42.15 | 100 | ATP binding |
| 31 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.5 | +2.1 | +2.3 | 5.30/42.15 | 587 | ATP binding |
| 32 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +3.7 | +2.2 | +2.5 | 5.30/42.15 | 81 | ATP binding |
| 33 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.0 | +1.2 | +2.1 | 5.30/42.15 | 611 | ATP binding |
| 34 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.0 | N | N | 5.30/42.15 | 650 | ATP binding |
| 13 | Actin, cytoplasmic type 5 | gi|56119084 | +3.2 | N | N | 5.30/42.15 | 235 | ATP binding |
| 36 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.5 | +2.5 | +1.9 | 5.30/42.15 | 741 | ATP binding |
| 45 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +8.9 | +9.4 | +4.0 | 5.30/42.15 | 837 | ATP binding |
| 53 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +1.6 | +1.5 | +1.3 | 5.30/42.15 | 618 | ATP binding |
| 58 | Actin, cytoplasmic type 5 (ACT5) | gi|56119084 | +2.2 | +2.5 | N | 5.30/42.15 | 523 | ATP binding |
| 9 | Vimentin | gi|212868 | -1.5 | -1.8 | -6.4 | 5.09/53.16 | 177 | Structural molecule activity |
| 12 | Vimentin | gi|212868 | +5.7 | N | N | 5.09/53.16 | 795 | Structural molecule activity |
| 55 | Lamin-B2(LMNB2) | gi|45384202 | +3.3 | N | N | 5.31/68.01 | 675 | Structural molecule activity |
|
| ||||||||
| 41 | PREDICTED: similar to D4-GDP-dissociation inhibitor (Rho-GDI) | gi|50728568 | +1.6 | N | N | 5.08/22.92 | 595 | Rho GDP-dissociation inhibitor activity |
| 67 | Rho GDP-dissociation inhibitor 1 (Rho-GDI) | gi|53126513 | -1.6 | -1.1 | N | 5.22/23.31 | 124 | Rho GDP-dissociation inhibitor activity |
|
| ||||||||
| 3 | Heat shock protein Hsp70 | gi|37590081 | -1.9 | -1.4 | -2.3 | 5.66/70.09 | 949 | Stress response |
| 6 | Heat shock cognate 71 kDa protein (HSPA8) | gi|45384370 | +3.0 | N | N | 5.47/71.01 | 591 | Stress response |
| 16 | 60 kDa heat shock protein, mitochondrial precursor (Hsp60) | gi|61098372 | +2.0 | +2.0 | N | 5.72/61.10 | 695 | Chaperone |
| 19* | Heat shock cognate 71 kDa protein | gi|45384370 | +4.3 | +2.1 | +2 | 5.47/71.01 | 38 | Stress response |
| 43 | Stress-70 protein, mitochondrial precursor | gi|57524986 | +1.4 | N | +2.2 | 6.09/73.43 | 68 | Cell proliferation and cellular aging |
| 60 | Heat shock protein HSP 90-alpha (Hsp90AA1) | gi|157954047 | -3.3 | -1.9 | N | 5.01/84.40 | 370 | ATP binding response to stress |
| 61 | Heat shock protein HSP 90-alpha (Hsp90AA1) | gi|157954047 | -1.4 | -1.8 | N | 5.01/84.40 | 544 | ATP binding response to stress |
| 10 | Cognin/prolyl-4-hydroxylase/protein disulfide isomerase(PDIA3) | gi|21703694 | +2.9 | +1.2 | +1.6 | 4.75/58.89 | 477 | Catalytic activity |
| 40 | Protein disulfide-isomerase A3 precursor (PDIA3) | gi|45383890 | +1.8 | N | N | 5.76/56.54 | 515 | Protein disulfide oxidoreductase activity |
|
| ||||||||
| 2* | Parvalbumin (pvalb1) | gi|225877920 | +2.7 | N | N | 4.94/12.06 | 44 | Calcium ion binding |
| 50 | Annexin A6 (ANXA6) | gi|50982399 | -2.1 | -1.4 | -2.1 | 5.57/75.57 | 180 | Calcium ion binding |
| 56 | Chain A, Crystal Structures Of Chicken Annexin V | gi|62738641 | -1.6 | -1.4 | -1.7 | 5.61/36.15 | 680 | Calcium ion binding |
|
| ||||||||
| 15 | Serpin B6 (SERPINB6) | gi|57530448 | +2.3 | N | N | 5.28/43.24 | 397 | Serine-type endopeptidase inhibitor activity |
| 70 | Cathepsin B (CTSB) | gi|603203 | +2.0 | +1.4 | +1.3 | 5.74/38.47 | 144 | Regulation of catalytic activity |
| 62 | Valosin containing protein | gi|90990971 | -4.0 | N | -1.48 | 5.14/89.95 | 636 | Nucleoside-triphosphatase activity |
| 37 | Ferritin H subunit | gi|21177 | +2.3 | +6.6 | +1.3 | 5.78/21.24 | 493 | Ferroxidase activity |
|
| ||||||||
| 1 | Gamma-glutamyltransferase (TGL2) | gi|62903517 | -2.7 | N | N | 4.90/79.11 | 875 | Gamma-glutamyltransferase activity |
| 5 | Argininosuccinate synthase(ASS1) | gi|61657937 | +2.1 | +1.4 | N | 6.10/47.33 | 872 | Arginine succinate synthetase activity |
| 8 | Pre-mRNA-processing factor 19 (PRPF19) | gi|86129600 | -1.9 | N | N | 6.19/55.55 | 394 | DNA binding DNA repair |
| 14 | PREDICTED: ribosomal protein SA isoform 1(RPSA) | gi|118086026 | +3.8 | N | N | 4.8/33.11 | 211 | Laminin receptor Activity( |
| 48* | Otokeratin | gi|3746660 | +1.7 | N | N | 5.97/53.77 | 56 | Structural molecule activity |
| 49 | Serum albumin precursor (VTDB) | gi|45383974 | -1.3 | N | -2.8 | 5.51/71.86 | 341 | Vitamin transporter activity |
| 57 | Chain B, Solution Nmr Structure Of V-1 Bound To Capping Protein | gi|297787504 | -1.7 | N | -1.4 | 5.5/30.71 | 457 | Actin binding |
| 59 | Alpha-tropomyosin (smooth muscle) | gi|212807 | +1.6 | N | +4.9 | 4.68/32.89 | 292 | Actin binding |
| 65 | Similar to MGC84496 protein | gi|118101652 | -1.5 | -1.4 | -2.3 | 6.07/22.80 | 176 | Unknown |
|
| ||||||||
| 4 | PREDICTED: hypothetical protein, partial | gi|118105147 | +1.1 | +1.7 | +1.4 | 4.77/66.11 | 147 | Unknown |
| 11 | Hypothetical protein | gi|53136508 | +2.0 | +1.2 | +1.9 | 6.22/53.74 | 257 | Unknown |
| 38 | Hypothetical protein | gi|53126859 | +13.8 | +7.2 | +6.0 | 5.31/42.10 | 535 | Unknown |
| 35 | Hypothetical protein | gi|53126859 | +4.1 | +3 | +2.9 | 5.31/42.10 | 650 | ATP binding |
| 51 | Hypothetical protein | gi|53126859 | -1.2 | -1.4 | -1.2 | 5.31/42.10 | 852 | Uknown |
| 52 | Hypothetical protein | gi|53126859 | +2.6 | +1.3 | +1.7 | 5.31/42.10 | 881 | Unknown |
| 54 | Hypothetical protein | gi|53126859 | -2.0 | -2.5 | -1.6 | 5.31/42.10 | 676 | Unknown |
| 69 | Hypothetical protein | gi|60098585 | -1.8 | -1.2 | -1.6 | 5.53/60.19 | 850 | Chaperone ATP binding |
a) Spot ID is the unique number that refers to the labels in Figure 3
b) Accession number: gi number in NCBI
c) Score: protein score based only on MS spectra by MALDI-TOF. Other spots were based on combined MS and MS/MS spectra from MALDI-TOF-TOF identification. A protein score greater than 83 is significant in this study (P < 0.05)
“-”, downregulated protein; “+”upregulated protein; “N”, no difference; “*”, failed identification
Fig. 3Venn diagram summarizing the spots that were significantly differentially expressed in the spleen tissues of REV-infected chickens according to their corresponding time of sampling. The identities of spots that were commonly expressed were placed in overlapping areas accordingly. The corresponding spot numbers are shown in parentheses. Refer to Table 1 for the respective protein names
Fig. 4Gene Ontology analysis of significantly changed proteins according to their biological process. This classification was produced based on the analysis using the GOSlimViewer tool at the Agbase database (http://www.agbase.msstate.edu/) as described in Materials and methods